Expression of HER1/EGFR protein in human soft tissue sarcomas

European Journal of Surgical Oncology

Volumn 32, Issue 4, 2006, Pages 466-468

  Yang, J L ^a   Hannan, M T ^a   Russell, P J ^a   Crowe, P J ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Epidermal growth factor receptor; Histological grade; Soft tissue sarcoma; Tumour markers

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADOLESCENT; ADULT; AGED; ANGIOSARCOMA; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; EPITHELIOID SARCOMA; GASTROINTESTINAL STROMAL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; LIPOSARCOMA; MALIGNANT FIBROUS HISTIOCYTOMA; MYXOSARCOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN TARGETING; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; SYNOVIAL SARCOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; SARCOMA; SEVERITY OF ILLNESS INDEX; TUMOR MARKERS, BIOLOGICAL;

EID: 33646492502     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.01.012     Document Type: Article

References (20)

1. Pollock R. Soft tissue sarcomas. In: Gansler T. (Ed). Atlas of clinical oncology (2000), BC Decker Inc., London
2. Gusterson B., Cowley G., Mcllhinney J., Ozanne B., Fisher C., and Reeves B. Evidence for increased epidermal growth factor receptors in human sarcomas. Int J Cancer 36 (1985) 689-693
3. Perosio P.M., and Brooks J.J. Expression of growth factors and growth factor receptors in soft tissue tumors. Implications for the autocrine hypothesis. Lab Invest 60 (1989) 245-253
4. Nielsen T.O., Hsu F.D., O'Connell J.X., Gilks C.B., Sorensen P.H., Linn S., et al. Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology. Am J Pathol 163 4 (2003) 1449-1456
5. Sato O., Wada T., Kawai A., Yamaguchi U., Makimoto A., Kokai Y., et al. Expression of epidermal growth factor receptor ERBB2 and KIT in adult soft tissue sarcomas. Cancer 103 (2005) 1881-1890
6. Ciardiello F., and Tortora G. A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clin Cancer Res 7 10 (2001) 2958-2970
7. Wells A. EGF receptor. Int J Biochem Cell Biol 31 6 (1999) 637-643
8. Woodburn J.R. The epidermal growth factor receptor and its inhibition in cancer therapy. Pharmacol Ther 82 2-3 (1999) 241-250
9. Einzinger L., and Weiss S.W. Soft tissue tumours. 3rd ed (1995), Mosby, St Louis
10. Coindre J.M., Terrier P., Guillou L., Le Doussal V., Collin F., Ranchere D., et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer 91 10 (2001) 1914-1926
11. Dei Tos A.P. The reappraisal of gastrointestinal stromal tumors: from Stout to the KIT revolution. Virchows Arch 442 5 (2003) 421-428
12. Yang J.L., Hanley J.R., Yu Y., Berney C.R., Russell P.J., and Crowe P.J. In vivo overexpression of c-erbB-2 oncoprotein in xenografts of mice implanted with human colon cancer lines. Anticancer Res 17 5A (1997) 3463-3468
13. Yang J.L., Jackson P., Yu Y., Yoshie O., Ham J., Russell P., et al. Invasion and metastasis correlate with down-regulation of KAI1 expression in human colon cancer cell lines. GI Cancer 3 5 (2001) 313-322
14. Paez J.G. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304 (2004) 1497-1500
15. Sordella R., Bell D.W., Haber D.A., and Settleman J. Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways. Science 305 (2004) 1163-1167
16. Fernberg J.O., Wiklund T., Monge O., Hall K.S., Saeter G., Alvegard T.A., et al. Chemotherapy in soft tissue sarcoma. The Scandinavian Sarcoma Group experience. Acta Orthop Scand Suppl 285 (1999) 62-68
17. Issels R.D., and Schlemmer M. Current trials and new aspects in soft tissue sarcoma of adults. Cancer Chemother Pharmacol 49 Suppl 1 (2002) S4-S8
18. Ciardiello F., and Tortora G. A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clin Cancer Res 7 10 (2001) 2958-2970
19. Smith J. Erlotinib: small-molecule targeted therapy in the treatment of non-small-cell lung cancer. Clin Ther 27 (2005) 1513-1534
20. Herbst R.S., Fukuoka M., and Baselga J. Gefitinib-a novel targeted approach to treating cancer. Nat Rev Cancer 4 (2004) 956-965